Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stuff is happening

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Oct 19, 2023 6:18pm

84 Views

Post# 35691968

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stuff is happening

grammar and sentence structure has nothing to do with the facts around ONCYs acquisition valuation. Unfortunately what you post fox.mf lacks credibility and is fairly perceived as deliberately inciteful to seemingly advance your negative cause. And then there is Quebec's Bill 96 which smacks with intolerance, and which should be enough of a response to speak to your point.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario